BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32685493)

  • 1. Cervical Dysplasia, Infection, and Phylogeny of Human Papillomavirus in HIV-Infected and HIV-Uninfected Women at a Reproductive Health Clinic in Nairobi, Kenya.
    Omire A; Budambula NLM; Kirumbi L; Langat H; Kerosi D; Ochieng W; Lwembe R
    Biomed Res Int; 2020; 2020():4945608. PubMed ID: 32685493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya.
    Guthrie BL; Rositch AF; Cooper JA; Farquhar C; Bosire R; Choi R; Kiarie J; Smith JS
    Sex Transm Infect; 2020 Sep; 96(6):457-463. PubMed ID: 31919275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN).
    Luque AE; Hitti J; Mwachari C; Lane C; Messing S; Cohn SE; Adler D; Rose R; Coombs R
    Int J Infect Dis; 2010 Sep; 14(9):e810-4. PubMed ID: 20655263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papilloma virus correlates of high grade cervical dysplasia in HIV-infected women in Mombasa, Kenya: a cross-sectional analysis.
    Menon S; Luchters S; Rossi R; Callens S; Kishor M; Bogers J; Vanden Broeck D
    Virol J; 2018 Mar; 15(1):54. PubMed ID: 29587796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus genotype profiles and cytological grades interlinkages in coinfection with HIV.
    Karani LW; Musyoki S; Orina R; Nyamache AK; Khayeka-Wandabwa C; Nyagaka B
    Pan Afr Med J; 2020; 35():67. PubMed ID: 32537071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
    Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
    BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of abnormal cervical cytology in HIV-infected women testing positive for both human papillomavirus and Epstein-Barr virus in genital tract specimens.
    Cameron JE; Dennis DC; Herrel NR; Chapple AG; Hagensee ME
    Cancer Causes Control; 2020 Apr; 31(4):365-375. PubMed ID: 32112173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus types prevalence and their association with cervical dysplasia among HIV and non-HIV infected women attending reproductive health clinics in Eastern Kenya.
    Kinotia NJ; Muturib M; Kamauc L; Lwembed R
    Afr Health Sci; 2022 Mar; 22(1):106-114. PubMed ID: 36032490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple human papillomavirus infections and HIV seropositivity as risk factors for abnormal cervical cytology among female sex workers in Nairobi.
    Patel SJ; Mugo NR; Cohen CR; Ting J; Nguti R; Kwatampora J; Waweru W; Patnaik P; Donders GG; Kimani J; Kenney DL; Kiviat NB; Smith JS
    Int J STD AIDS; 2013 Mar; 24(3):221-5. PubMed ID: 23535357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi.
    Motti PG; Dallabetta GA; Daniel RW; Canner JK; Chiphangwi JD; Liomba GN; Yang L; Shah KV
    J Infect Dis; 1996 Mar; 173(3):714-7. PubMed ID: 8627037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus infection in HIV-1 infected women in Catalonia (Spain): implications for prevention of cervical cancer.
    Stuardo V; Agustí C; Godinez JM; Montoliu A; Torné A; Tarrats A; Alcalde C; Martín D; Fernández-Montoli E; Vanrell C; Solé J; Canet Y; Marqueta JM; Mohamed J; Cuenca I; Lonca M; Sirera G; Ferrer E; Domingo P; Lloveras B; Miro JM; De Sanjosé S; Casabona J
    PLoS One; 2012; 7(10):e47755. PubMed ID: 23118894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
    Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
    J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
    Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
    BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    Zhang J; Zhang D; Yang Z; Wang X; Wang D
    BMC Cancer; 2020 May; 20(1):443. PubMed ID: 32429919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection.
    Yamada R; Sasagawa T; Kirumbi LW; Kingoro A; Karanja DK; Kiptoo M; Nakitare GW; Ichimura H; Inoue M
    J Med Virol; 2008 May; 80(5):847-55. PubMed ID: 18360898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus infection: low-risk and high-risk genotypes in women in Catania, Sicily.
    Agodi A; Barchitta M; La Rosa N; Cipresso R; Guarnaccia M; Caruso M; Castiglione MG; Ettore G; Travali S
    Int J Gynecol Cancer; 2009 Aug; 19(6):1094-8. PubMed ID: 19820375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
    Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
    Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York.
    Luque AE; Jabeen M; Messing S; Lane CA; Demeter LM; Rose RC; Reichman RC
    J Infect Dis; 2006 Aug; 194(4):428-34. PubMed ID: 16845625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.
    Macleod IJ; O'Donnell B; Moyo S; Lockman S; Shapiro RL; Kayembe M; van Widenfelt E; Makhema J; Essex M; Wester C
    J Med Virol; 2011 Oct; 83(10):1689-95. PubMed ID: 21837784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.